Clorox Co (NYSE:CLX) Stock Holdings Decreased by Shell Asset Management Co.

Shell Asset Management Co. lowered its stake in Clorox Co (NYSE:CLX) by 4.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 48,838 shares of the company’s stock after selling 2,159 shares during the period. Shell Asset Management Co.’s holdings in Clorox were worth $8,461,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wealth Quarterback LLC bought a new stake in shares of Clorox during the 4th quarter valued at about $18,905,411,000. BlackRock Inc. grew its position in shares of Clorox by 8.1% during the 1st quarter. BlackRock Inc. now owns 11,551,578 shares of the company’s stock valued at $2,001,312,000 after buying an additional 866,360 shares during the last quarter. State Street Corp grew its position in shares of Clorox by 1.4% during the 4th quarter. State Street Corp now owns 8,449,667 shares of the company’s stock valued at $1,297,362,000 after buying an additional 112,927 shares during the last quarter. Parnassus Investments CA grew its position in shares of Clorox by 8.6% during the 4th quarter. Parnassus Investments CA now owns 5,049,429 shares of the company’s stock valued at $775,289,000 after buying an additional 397,930 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Clorox by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 2,289,986 shares of the company’s stock valued at $350,986,000 after buying an additional 47,696 shares during the last quarter. 76.45% of the stock is owned by institutional investors.

Shares of NYSE:CLX traded down $0.81 during trading on Friday, reaching $198.59. The company had a trading volume of 1,213,707 shares, compared to its average volume of 2,024,068. The firm’s fifty day moving average is $193.16 and its 200 day moving average is $167.10. The firm has a market capitalization of $25.11 billion, a PE ratio of 29.12, a price-to-earnings-growth ratio of 5.01 and a beta of 0.24. Clorox Co has a twelve month low of $144.12 and a twelve month high of $214.26. The company has a debt-to-equity ratio of 3.69, a quick ratio of 0.72 and a current ratio of 0.98.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Friday, May 1st. The company reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.67% and a return on equity of 147.52%. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.44 EPS. Equities analysts predict that Clorox Co will post 6.89 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Wednesday, July 29th will be paid a $1.11 dividend. This is a positive change from Clorox’s previous quarterly dividend of $1.06. This represents a $4.44 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date is Tuesday, July 28th. Clorox’s dividend payout ratio is currently 67.09%.

In related news, CFO Kevin B. Jacobsen sold 15,066 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $206.59, for a total value of $3,112,484.94. Following the sale, the chief financial officer now directly owns 21,452 shares in the company, valued at approximately $4,431,768.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Benno O. Dorer sold 252,794 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $169.01, for a total transaction of $42,724,713.94. Following the completion of the sale, the chief executive officer now owns 306,908 shares in the company, valued at $51,870,521.08. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 300,843 shares of company stock valued at $52,556,301. Company insiders own 1.14% of the company’s stock.

CLX has been the subject of a number of recent research reports. Morgan Stanley boosted their price objective on shares of Clorox from $173.00 to $177.00 and gave the company an “underweight” rating in a research report on Monday, May 4th. Royal Bank of Canada reissued a “hold” rating and set a $195.00 target price on shares of Clorox in a research note on Tuesday, April 14th. Credit Suisse Group boosted their target price on shares of Clorox from $172.00 to $180.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Barclays reissued a “sell” rating and set a $164.00 target price on shares of Clorox in a research note on Tuesday, May 5th. Finally, Cfra boosted their target price on shares of Clorox from $170.00 to $190.00 and gave the company a “hold” rating in a research note on Friday, May 1st. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Clorox has a consensus rating of “Hold” and a consensus price target of $173.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: What does cost of debt say about a company’s financial health?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.